Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -164,826 | -96,318 | -50,457 | -26,066 | -102,985 |
| Depreciation Amortization | 10,705 | 6,733 | 4,277 | 1,911 | 10,947 |
| Accounts receivable | 768 | -7,743 | -2,208 | -160 | -10,438 |
| Other Working Capital | 36,373 | 20,156 | -2,874 | 4,190 | -4,781 |
| Other Operating Activity | 440 | -672 | -4,886 | -1,563 | 23,575 |
| Operating Cash Flow | $-116,540 | $-77,844 | $-56,148 | $-21,688 | $-83,682 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15,946 | -12,439 | -4,898 | -458 | -5,964 |
| Purchase Sale Intangibles | -400 | -400 | -400 | N/A | -1,200 |
| Other Investing Activity | 56,460 | -400 | -400 | 0 | -1,200 |
| Investing Cash Flow | $40,514 | $-12,839 | $-5,298 | $-458 | $-7,164 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 7,000 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 60,000 |
| Debt Repayment | -10,450 | N/A | N/A | -13 | -78,223 |
| Common Stock Issued | 9,679 | 453 | 302 | 165 | 46,479 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -70 |
| Dividend Paid | -8,780 | -6,585 | -4,390 | -2,194 | -6,752 |
| Other Financing Activity | 151,545 | 116,185 | 107,175 | 80,734 | 150,976 |
| Financing Cash Flow | $148,994 | $110,053 | $103,087 | $78,692 | $172,410 |
| Beginning Cash Position | 234,996 | 234,996 | 234,996 | 234,996 | 153,432 |
| End Cash Position | 307,964 | 254,366 | 276,637 | 291,542 | 234,996 |
| Net Cash Flow | $72,968 | $19,370 | $41,641 | $56,546 | $81,564 |
| Free Cash Flow | |||||
| Operating Cash Flow | -116,540 | -77,844 | -56,148 | -21,688 | -83,682 |
| Capital Expenditure | -15,946 | -12,439 | -4,898 | -458 | -5,964 |
| Free Cash Flow | -132,486 | -90,283 | -61,046 | -22,146 | -89,646 |